Expensive Drugs: Only At First Glance

We concur with a recent article by Peter J. Pitts, a former FDA associate commissioner ("Why ‘Pricey’ Drugs Save Money — and Lives," in the New York Post.  In that article Pitts argues against expensive new drugs as the culprit to rising US health-care costs.


Pillars of U.S. Physician Office Testing – Clinical Chemistry

Clinical chemistry panels and parameters represent the fourth-most commonly performed test in U.S. POLs behind dipstick urinalysis, the complete blood count (CBC), and prothrombin time (PT). Seeking to transcend the low ceilings for growth in traditional clinical lab markets, IVD companies have developed numerous systems to perform core lab tests without the footprint or complexity of centralized lab platforms. The result has been benchtop and portable clinical chemistry analyzers equally applicable to the POLs of developed markets and resource-strained clinical labs of the developing world. The results from several routine chemistry panels and many conventional chemistry parameters are now available to patients during the same consultation or visit, informing physicians to investigate more specific diagnoses.

No Simple Patch-Ups in the Advanced Wound Care Market

Gauzes, disinfectants, bandages – even sutures and staples – form a recognizable veneer in wound care and, in terms of their market, obscure the products and innovation most responsible for driving overall market growth. Biological dressings are projected to be the second-fastest growing wound care market segment through 2018 behind only negative pressure wound therapy (NPWT). Primary product categories in biological dressings for wound care include skin substitutes (cellular and tissue-based products), collagen dressings, and growth factors.


Pillars of U.S. Physician Office Testing – Prothrombin Time (PT/INR)

Prothrombin time is also among the most-performed in-office tests in other developed nations with significant POL segments such as Switzerland and Germany. With over 4 million warfarin patients at any one time, the United States represents the largest national coagulation test market in the world. Kalorama Information estimates that approximately 20 million POL PT/INR tests are performed in the United States each year.

‘Dengue Mata’ – A Look at Brazilian Disease Control during and past the World Cup

Significant International transmission of dengue is an unlikely outcome, though the disease's threat endures in Brazil past its World Cup spotlight. Behind the disease control initiatives discussed in this article, dengue diagnostics play a significant role in public health and disease surveillance in Brazil. For the latest full year (2013), Brazil reported approximately 1.5 million cases of dengue and the publicly funded health care system Sistema Único de Saúde (SUS) received claims for approximately 720,000 immunoassays (550,000 IgM and 170,000 IgG) representing approximately $20 million in testing value.


Subscribe to Kalorama Information Home RSS